• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: WELLY HEALTH PBC WELLY FACE SAVER; DRESSING, WOUND, HYDROPHILIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

WELLY HEALTH PBC WELLY FACE SAVER; DRESSING, WOUND, HYDROPHILIC Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Erythema (1840); Ulcer (2274); Skin Inflammation/ Irritation (4545)
Event Date 07/22/2023
Event Type  Injury  
Manufacturer Narrative
The device was used for treatment, not diagnosis.Device was not returned for manufacturer review/investigation since it is single use bandage.Device evaluation by the manufacturer could therefore not be completed.This report and the information submitted under this report do not constitute an admission that the device or welly health or any of its employees caused or contributed to the event described herein or that the event as reported to welly health occurred.
 
Event Description
This spontaneous report was received via email on 06-aug-2023 on behalf of a 5-year-old, female consumer regarding her use of welly health's face savers.Medical history included an unspecified skin condition described as "skin irritations." the parent of the consumer who experienced the event reported that during the weekend of (b)(6) 2023, a face saver was applied to an area of skin that was irritated in unspecified locations and attempted to use the product as directed on the package instructions.The consumer had a history of recurrent, irritated skin areas that required an ongoing care regimen that included medicating and bandaging affected areas.An unspecified amount of time after application of the face saver, the consumer developed worsening irritation, redness and swelling of the affected area that eventually evolved into sores on her skin.The product was removed, however, the skin sores continued to worsen.On an unspecified date, the consumer's pediatrician was contacted via email.On 24-jul-2023, the physician responded advising that alternative bandaging be used along with the consumer's normal skin care regimen which included sensitive-skin soaps and lotions along with the application of topical benadryl (diphenhydramine) and neosporin as needed.On (b)(6) 2023 the consumer reported that the areas experiencing the adverse conditions in which the face savers were applied worsened requiring prescribed medications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WELLY FACE SAVER
Type of Device
DRESSING, WOUND, HYDROPHILIC
Manufacturer (Section D)
WELLY HEALTH PBC
700 nicollet mall, suite 800
minneapolis MN 55402
Manufacturer (Section G)
WELLY HEALTH PBC
700 nicollet mall, suite 800
MN 55402
Manufacturer Contact
joe ciccone
700 nicollet mall, suite 800
8565811481
MDR Report Key17665721
MDR Text Key322471637
Report Number3016050930-2023-00005
Device Sequence Number1
Product Code NAC
UDI-Device Identifier00810010441775
UDI-Public810010441775
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 08/31/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 08/06/2023
Initial Date FDA Received08/31/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
GUMMY MULTIVITAMIN.; ORAL ANTIBIOTIC.; ORAL ANTIHISTAMINES.; TOPICAL ANTIBIOTICS.; TOPICAL ANTIFUNGALS.; TOPICAL STEROIDS.; VITAMIN D.
Patient Outcome(s) Required Intervention;
Patient Age5 YR
Patient SexFemale
-
-